MammoCheck
MammoCheck is a Cyprus-based healthtech startup spun out of Frederick University, building a Software-as-a-Medical-Device platform that combines a thermal camera, a smartphone app and a proprietary AI algorithm for radiation-free, compression-free at-home breast-health monitoring between mammograms, flagging changes in thermal patterns for clinical review.
About
MammoCheck is a Cyprus-based healthtech startup spun out of Frederick University, building a Software-as-a-Medical-Device platform that combines a thermal camera, a smartphone app and a proprietary AI algorithm for radiation-free, compression-free at-home breast-health monitoring between mammograms, flagging changes in thermal patterns for clinical review. It is pursuing FDA 510(k) clearance and CE marking.
Capital graph
Founders / team· 2
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- MammoCheck
At-home breast health monitoring SaMD platform combining a thermal camera, mobile app and AI algorithms, as an adjunct to mammography and ultrasound screening, for women at home and clinic-assisted screening
—
United States
BusinessLatest roundTotal raisedDate- Mira
Connected at-home hormone monitor, disposable test sticks, AI analysis app and online hormone health clinic for women trying to conceive, with PCOS or in perimenopause, and partner fertility clinics, using AI to read urine hormone levels and predict ovulation windows, bringing lab-grade hormone data home
$5M
$5M - Clair Health
Noninvasive continuous hormone-monitoring wearable and companion app for women, using machine learning to infer hormone levels from biosensor data
$12M
$12M - code:blue
Passive monitoring of early stroke signs with automatic alerts, using computer vision and voice AI on existing phone/computer cameras and microphones
—
China
BusinessLatest roundTotal raisedDate- SleepWell Technology Corp.
AI sleep health screening and brainwave intervention (smartphone face-scan screening + brainwave eye mask)
— - DeepInformatics++
AI + digital pathology focused on core diagnostic needs: full-chain digital pathology department solutions incl. smart scanning, QC and multi-cancer analysis; develops the DeepPathAI pathology model.
Series C · 2026-07
— - 睿心医疗
Developer of AI precision diagnosis and treatment platforms for cardiovascular and cerebrovascular disease and of vascular interventional surgical robots.
Strategic · 2026-07
—
Europe
BusinessLatest roundTotal raisedDate- Blue Box Biomedical
Early breast cancer screening devices using saliva samples and AI
Seed · $4M · 2025-07
$4M - ThinkSono
Transforming medical imaging with AI-guided ultrasound solutions
Undisclosed · $3M · 2024-03
$3M - Neko Health
Provides full-body preventive health scans using sensors and blood analysis
Series C · $1.0B · 2026-07
$1.0B
Other / unspecified
BusinessLatest roundTotal raisedDate- Oncoustics
Point-of-care ultrasound AI software (OnX platform) for non-invasive liver disease detection and monitoring from raw acoustic signals ("virtual biopsy")
$764K
$764K - ICLO
Homeden smartphone-photo AI oral screening: deep learning detects cavities, tartar, gum disease and more and grades severity; Homeden Connect provides patient referrals and CRM for partner dental clinics; also sells intraoral cameras and other hardware.
— - Sonaro
AI software medical device Vaso3D™ that turns 2D carotid ultrasound into 3D vascular models for stroke-risk screening at healthcare providers
—
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.